Be the first to know about every new Coronavirus story

The vaccination rollout is helping the world fight the coronavirus pandemic but unequal access, vaccine hesitancy, and manufacturing bottlenecks remain big problems. Ugur Sahin, co-founder of BioNTech, Kate Bingham, managing-partner at SV Health Investors who was the first head of the UK’s vaccine task force, and Seth Berkley, chief executive of the Gavi global health alliance, discuss with FT Science Editor Clive Cookson how the world can do better in future. Also participating was Martin Lush, global vice-president at NSF, an international organisation developing public health standards.

Visit ft.com/globalboardroom to sign up for your free pass to The Global Boardroom, a flagship FT Live event where top FT editors will interview 120 leaders in fields ranging from healthcare to foreign policy. The conference runs for three days until Thursday 6 May. Premium subscribers can also obtain a free professional pass using the code PREMIUM200, with perks including on-demand video of all sessions for 90 days.


Get alerts on Covid-19 vaccines when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window)

Follow the topics in this article